The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

MEDNAX Inc

NYSE: MD
Last

(U.S.) $67.04

Today's change+0.13 +0.19%
Updated December 19 4:09 PM EST. Delayed by at least 15 minutes.
 

MEDNAX Inc

NYSE: MD
Last

(U.S.) $67.04

Today's change+0.13 +0.19%
Updated December 19 4:09 PM EST. Delayed by at least 15 minutes.

MEDNAX Inc Hits New 52-week High

MEDNAX Inc closed up Friday by (U.S.)$0.13 or 0.19% to (U.S.)$67.04 and setting a new 52-week high. Over the last five days, shares have gained 3.68% and 25.59% year to date. Shares have outperformed the S&P 500 by 13.70% during the last year.

Key company metrics

  • Open(U.S.) $66.88
  • Previous close(U.S.) $66.91
  • High(U.S.) $67.40
  • Low(U.S.) $66.46
  • Bid / Ask-- / --
  • YTD % change+25.59%
  • Volume1,032,510
  • Average volume (10-day)751,864
  • Average volume (1-month)673,998
  • Average volume (3-month)720,358
  • 52-week range(U.S.) $49.82 to (U.S.) $67.40
  • Beta0.71
  • Trailing P/E21.83×
  • P/E 1 year forward21.30×
  • Forward PEG1.56×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.07
Updated December 19 4:09 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+13.07%

Based on its net profit margin of 13.07%, MEDNAX Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue627596566567
Total other revenue--------
Total revenue627596566567
Gross profit210201173190
Total cost of revenue416395393377
Total operating expense488466462443
Selling / general / administrative61615856
Research & development--------
Depreciation / amortization11101010
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income138130104124
Interest income (expense), net non-operating-2-2-1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax137128104123
Income after tax86796479
Income tax, total51494144
Net income86796479
Total adjustments to net income--------
Net income before extra. items86796479
Minority interest000--
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items86796479
Inc. avail. to common incl. extra. items86796479
Diluted net income86796479
Dilution adjustment------0
Diluted weighted average shares100100100101
Diluted EPS excluding extraordinary itemsvalue per share0.860.790.640.78
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.860.790.640.78